Kim Schønnemann Bøttkjær

FIH Partners A/S offers corporate finance advisory services. The firm provides financial advising to large and mid-size corporations, financial sponsors, and government institutions as part of divestments, mergers, acquisitions, initial public offerings, and other equity and debt capital market matters. The company was founded by Kim Schønnemann Bøttkjær, Oscar Mosgaard, Ulrik Falk, Henrik Krüger, and Jørgen Overholt Hansen in 2006 and is headquartered in Coppenhagen, Denmark.

Glycom A/S engages in the development, synthesis, and commercialization of human milk oligosaccharides. It develops chemical and enzymatic technologies for synthesis of human milk oligosaccharide powders. The company was founded by Gyuala Dekany, Mark von Itzstein, Joachim Erich Thiem, Arnold Stutz, and Inge Lundt on March 22, 2005 and is headquartered in Horsholm, Denmark.

Valderm ApS is focused on the development of the second generation anthracycline valrubicin for innovative once daily topical treatment of hyper proliferative skin diseases e.g. psoriasis. Preclinical studies have confirmed the anti-proliferative effect of valrubicin and an attractive safety profile upon repeated topical applications has been documented. The company was founded in 2003 and is headquartered in Lyngby, Denmark.